TRCT
FBT icon

Tower Research Capital (TRC)’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Tower Research Capital (TRC)’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.61M Buy
+17,980
New +$3.72M 0.09% 215
2025
Q4 		– Sell
-1
Closed -$179 – 5277
2025
Q3 		$179 Sell
1
-8
-89% -$1.36K ﹤0.01% 5082
2025
Q2 		$1.45K Buy
9
+7
+350% +$1.11K ﹤0.01% 4813
2025
Q1 		$340 Hold
2
– – ﹤0.01% 4931
2024
Q4 		$332 Buy
2
+1
+100% +$171 ﹤0.01% 5318
2024
Q3 		$172 Sell
1
-3
-75% -$497 ﹤0.01% 5446
2024
Q2 		$616 Buy
4
+2
+100% +$300 ﹤0.01% 5287
2024
Q1 		$308 Sell
2
-1
-33% -$152 ﹤0.01% 5551
2023
Q4 		$474 Sell
3
-1
-25% -$144 ﹤0.01% 5563
2023
Q3 		$585 Sell
4
-6
-60% -$914 ﹤0.01% 5531
2023
Q2 		$1.53K Buy
10
+6
+150% +$936 ﹤0.01% 5361
2023
Q1 		$1K Buy
+4
New +$628 ﹤0.01% 5529
2022
Q4 		– Sell
-15,325
Closed -$2.02M – 6024
2022
Q3 		$2.02M Sell
15,325
-5,362
-26% -$752K 0.03% 414
2022
Q2 		$2.8M Buy
20,687
+7,367
+55% +$1.02M 0.06% 264
2022
Q1 		$1.99M Sell
13,320
-2,050
-13% -$303K 0.02% 576
2021
Q4 		$2.49M Sell
15,370
-6,201
-29% -$1M 0.04% 351
2021
Q3 		$3.58M Buy
21,571
+8,199
+61% +$1.4M 0.09% 142
2021
Q2 		$2.31M Sell
13,372
-2,328
-15% -$384K 0.06% 268
2021
Q1 		$2.52M Buy
15,700
+8,182
+109% +$1.4M 0.04% 400
2020
Q4 		$1.26M Sell
7,518
-12,178
-62% -$1.98M 0.04% 390
2020
Q3 		$3.1M Sell
19,696
-15,400
-44% -$2.52M 0.03% 184
2020
Q2 		$5.89M Buy
35,096
+6,720
+24% +$1.05M 0.24% 51
2020
Q1 		$3.72M Buy
28,376
+22,044
+348% +$3.14M 0.23% 52
2019
Q4 		$942K Sell
6,332
-37,232
-85% -$5.11M 0.08% 127
2019
Q3 		$5.39M Buy
43,564
+19,286
+79% +$2.57M 0.37% 32
2019
Q2 		$3.42M Buy
24,278
+22,750
+1,489% +$3.14M 0.23% 55
2019
Q1 		$230K Sell
1,528
-2,446
-62% -$352K 0.01% 1083
2018
Q4 		$493K Sell
3,974
-6,327
-61% -$865K 0.04% 426
2018
Q3 		$1.63M Sell
10,301
-6,644
-39% -$1.01M 0.12% 134
2018
Q2 		$2.37M Buy
16,945
+12,857
+315% +$1.77M 0.13% 139
2018
Q1 		$543K Sell
4,088
-16,599
-80% -$2.27M 0.05% 434
2017
Q4 		$2.58M Sell
20,687
-2,985
-13% -$369K 0.33% 51
2017
Q3 		$2.93M Buy
+23,672
New +$2.8M 0.24% 57
2017
Q2 		– Sell
-1,683
Closed -$177K – 2926
2017
Q1 		$177K Sell
1,683
-16,331
-91% -$1.64M 0.02% 306
2016
Q4 		$1.64M Sell
18,014
-3,965
-18% -$371K 0.18% 117
2016
Q3 		$2.19M Sell
21,979
-43,136
-66% -$4.23M 0.22% 49
2016
Q2 		$5.82M Sell
65,115
-20,642
-24% -$1.9M 0.56% 28
2016
Q1 		$7.51M Buy
+85,757
New +$7.55M 1.12% 15
2015
Q4 		– Sell
-84,667
Closed -$8.58M – 4633
2015
Q3 		$8.58M Buy
84,667
+78,711
+1,322% +$9.36M 0.83% 10
2015
Q2 		$739K Sell
5,956
-17,012
-74% -$2.05M 0.07% 111
2015
Q1 		$2.72M Buy
+22,968
New +$2.6M 0.34% 40
2014
Q4 		– Sell
-35,528
Closed -$3.26M – 4198
2014
Q3 		$3.26M Buy
35,528
+26,381
+288% +$2.29M 0.37% 52
2014
Q2 		$753K Buy
+9,147
New +$699K 0.1% 147

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Tower Research Capital (TRC)'s FBT Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026: 17,980 shares worth $3.61M. The stake represents 0.09% of the portfolio and ranks #215 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in FBT as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in FBT in Q2 2014 and has held it in 43 quarters since. The position peaked at $8.58M in Q3 2015. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Tower Research Capital (TRC) held 17,980 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.61M as of Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Tower Research Capital (TRC) position in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.09% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #215 holding.
  • Tower Research Capital (TRC) first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2014 and has held it in 43 quarters since.
  • Tower Research Capital (TRC)'s First Trust NYSE Arca Biotechnology Index Fund position peaked at $8.58M in Q3 2015.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.